Difficulty: Medium
Average Score: 63%
Practice
Nondepolarisation neuromuscular blocking agents:
Correct answer
B
Rationale
In the context of pharmacology of cardiovascular drugs, understanding the mechanism of action of nondepolarising neuromuscular blocking agents is crucial for safe and effective patient care.
Option B, "Prevent access of the transmitter to its receptor and depolarization," is the correct answer. Nondepolarising neuromuscular blocking agents work by competitively binding to the nicotinic acetylcholine receptors at the neuromuscular junction, thereby preventing acetylcholine from binding and depolarizing the muscle cell membrane. This results in muscle relaxation and paralysis, which is desirable in certain clinical situations such as during surgery to facilitate endotracheal intubation or to assist with mechanical ventilation.
Option A, "Block acetylcholine reuptake," is incorrect because nondepolarising neuromuscular blocking agents do not block acetylcholine reuptake. Instead, they interfere with the binding of acetylcholine to its receptor.
Option C, "Block transmission by an excess of a depolarizing agonist," is also incorrect. This option describes the mechanism of depolarising neuromuscular blocking agents like succinylcholine, which cause sustained depolarization of the muscle membrane leading to muscle paralysis through persistent activation of the nicotinic receptor.
By grasping the distinctions between various neuromuscular blocking agents, healthcare providers can select the appropriate medication based on the clinical scenario, thereby improving patient outcomes and reducing the risk of complications.
Option B, "Prevent access of the transmitter to its receptor and depolarization," is the correct answer. Nondepolarising neuromuscular blocking agents work by competitively binding to the nicotinic acetylcholine receptors at the neuromuscular junction, thereby preventing acetylcholine from binding and depolarizing the muscle cell membrane. This results in muscle relaxation and paralysis, which is desirable in certain clinical situations such as during surgery to facilitate endotracheal intubation or to assist with mechanical ventilation.
Option A, "Block acetylcholine reuptake," is incorrect because nondepolarising neuromuscular blocking agents do not block acetylcholine reuptake. Instead, they interfere with the binding of acetylcholine to its receptor.
Option C, "Block transmission by an excess of a depolarizing agonist," is also incorrect. This option describes the mechanism of depolarising neuromuscular blocking agents like succinylcholine, which cause sustained depolarization of the muscle membrane leading to muscle paralysis through persistent activation of the nicotinic receptor.
By grasping the distinctions between various neuromuscular blocking agents, healthcare providers can select the appropriate medication based on the clinical scenario, thereby improving patient outcomes and reducing the risk of complications.